Emerson Exchange 365

In the life sciences industries, the digital twin is proven and accepted for offline testing of the control system in design/implement/test activities, software and factory integration and the system acceptance testing phases of installation qualification and operational qualification. In addition, a digital twin can be used to provide more effective competency assessment and procedure development.

The life sciences industry has typically viewed simulation as discretionary. Simulation and the digital twin brings value to the industry in these five areas:

• Reduces the time associated with operational qualification and installation qualification activities through earlier and more comprehensive testing of the process and control system.
• Accelerates the process from drug development through to production using the accuracy and engineering support provided by the digital twin.
• Enables cost-effective compliance and validation of the process control system, as well as operating procedures.
• Provides a platform for operations training and competency assessment.
• Allows comprehensive testing and integration of the control system with higher level 3 systems such as an MES. Entire campaigns are designed and planned with zero impact on actual production.

Ronnie Bains, Director of Process Simulation for Europe, discusses new features requested by users in pharma as well as how he thinks modeling and simulation systems will adapt to meet the industry's needs. Read more here.